Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii

Parasitology Research

Volumn 111, Issue 1, 2012, Pages 403-411

  Khosroshahi, Kamy Hosseinian ^a   Ghaffarifar, Fatemeh ^a   Sharifi, Zohre ^b   D'Souza, Sushila ^c   Dalimi, Abdolhosein ^a   Hassan, Zuhair M ^a   Khoshzaban, Fariba ^d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^d SHAHED UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 4; PARASITE ANTIGEN; RHOPTRY ANTIGEN 2; SURFACE MAJOR ANTIGEN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENCY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; OPTICAL DENSITY; PLASMID; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; INTERLEUKIN-12; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PLASMIDS; PROTOZOAN PROTEINS; SURVIVAL ANALYSIS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

MUS; TOXOPLASMA GONDII;

EID: 84862766439     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-012-2852-7     Document Type: Article

References (38)

1. GM Bhopale 2003 Development of a vaccine for Toxoplasmosis: current status Microbiol Infect 5 457 462 10.1016/S1286-4579(03)00048-0 1:CAS:528:DC%2BD3sXjsVGksLY%3D
2. C Bonenfant I Dimier-Poisson F Velge-Roussel D Buzoni-Gantel GD Giudice R Rappuoli D Bout 2001 Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii Infect Immun 69 1605 1612 11179334 10.1128/IAI.69.3.1605-1612.2001 1:CAS:528: DC%2BD3MXitFGrtbY%3D
3. DA Brake 2002 Vaccinology for control of apicomplexan parasites: a simplified language of immune programming and its use in vaccine design Int J Parasitol 32 509 515 11943223 10.1016/S0020-7519(01)00353-8 1:CAS:528: DC%2BD38Xis1eisLo%3D
4. JL Burg D Perelman LH Kasper PL Ware JC Bothroyd 1988 Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii J Immunol 141 10 3584 3591 3183382 1:CAS:528:DyaL1MXkvFWnsLs%3D
5. KN Couper H Nielsen E Petersen F Roberts CW Roberts J Alexander 2003 DNA vaccination with the immunodominant tachyzoite surface antigen (SAG1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission Vaccine 21 2813 2820 12798622 10.1016/S0264-410X(03) 00163-4 1:CAS:528:DC%2BD3sXksVyru7Y%3D
6. A Crampton T Vanniasinkam 2007 Parasite vaccines: the new generation Infect Genet Evol 7 664 673 17702669 10.1016/j.meegid.2007.06.004 1:CAS:528:DC%2BD2sXhtVWhsrrK
7. Crowther JR (1995) ELISA, theory and practice. Humana Press, New Jersey
8. AF Cuppari V Sancheza B Ledesma FM Frank A Goldman SO Angel V Marti 2008 Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis Vaccine 26 5040 5045 18675873 10.1016/j.vaccine.2008.07. 031 1:CAS:528:DC%2BD1cXhtVynsL7N
9. B Delsolme MN Mevelec D Buzoni-Gatel D Bout 2000 Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene Vaccine 18 2512 2521 10.1016/S0264-410X(00) 00035-9
10. A Fachado A Rodriguez SO Angel DC Pinto I Vila A Acosta RR Amendoeira J Lannes-Vieira 2003 Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice Vaccine 21 1327 1335 12615427 10.1016/S0264- 410X(02)00692-8 1:CAS:528:DC%2BD3sXhs1KntLk%3D
11. Farnandez-Botran R, Vetyickaz V (2001) Methods in cellular immunology, 2nd edn. CRF Press Inc., Portland
12. M Haumont L Delhaye L Garcia M Jurado P Mazzu V Daminet V Verlant A Bollen R Biemans A Jacquet 2000 Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a Guinea pig model Infect Immun 68 4948 4953 10948109 10.1128/IAI.68.9.4948-4953.2000 1:CAS:528: DC%2BD3cXmtVelu7o%3D
13. SL Hem H Hogenesch 2007 Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation Expert Rev Vaccines 6 685 698 17931150 10.1586/14760584.6.5.685 1:CAS:528: DC%2BD2sXhtFGgsr3N
14. K Hosseinian Khosroshahi F Ghaffari far Z Sharifi A Dalimi 2008 Expression of complete rhoptry protein 2 (ROP2) gene of Toxoplasma gondii in eukaryotic cell Afr J Biotechnol 7 4432 4436 1:CAS:528:DC%2BD1MXmt1Sktw%3D%3D
15. K Hosseinian Khosroshahi F Ghaffarifar Z Sharifi S D'Souza A Dalimi 2011 Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis Vaccine 29 778 783 10.1016/j.vaccine.2010.11.012
16. S Hunter L Ashbaugh P Hiar CM Bozic M Milhausen 1999 Baculovirus-directed expression and secretion of a truncated version of Toxoplasma SAG1 Mol Biochem Parasitol 103 267 272 10551369 10.1016/S0166-6851(99)00119-X 1:CAS:528:DyaK1MXmsVWmsbs%3D
17. E Jongert WC Roberts N Gargano E Forster-Waldl E Petersen 2009 Vaccines against Toxoplasma gondii :challenges and opportunities Mem Inst Oswaldo Cruz 104 252 266 19430651 10.1590/S0074-02762009000200019 1:CAS:528: DC%2BD1MXotFOksr8%3D
18. EN Kimbita X Xuan X Huang T Miyazawa S Fukumoto M Mishima H Suzuki C Sugimoto I Iqarashi 2001 Serodiagnosis of Toxoplasma gondii infection in cate by enzyme-linked immunosorbent assay using recombinant SAG1 Vet Parasitol 102 35 44 11705650 10.1016/S0304-4017(01)00522-2 1:CAS:528:DC%2BD3MXot1Ogs74%3D
19. W Kofta H Wedrychowicz 2001 c-DNA vaccination against parasitic infections: advantages and disadvantages Vet Parasitol 100 3 12 11522401 10.1016/S0304-4017(01)00478-2 1:CAS:528:DC%2BD3MXmtV2nt70%3D
20. R Leyva P Herion R Saavedra 2001 Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii Parasitol Res 87 70 79 11199854 10.1007/s004360000296 1:STN:280:DC%2BD3MzitFajtg%3D%3D
21. V Martin A Supanitsky PC Echeverria S Litwin T Tanos AR De Roodt EA Guarnera SO Angel 2004 Recombinant GRA4 or ROP2 protein combined with alum or the GRA4 gene provides partial protection in chronic murine models of toxoplasmosis Clin Diagn Lab Immunol 11 704 710 15242945 1:CAS:528: DC%2BD2cXmsFaqurg%3D
22. E Peterson VN Henrik L Christiansen J Spenter 1998 Immunization with E.coli produced recombinant Toxoplasma gondii SAG1 with alum as adjuvant protects mice against lethal infection with Toxoplasma gondii Vaccine 16 1283 1289 10.1016/S0264-410X(98)00039-5
23. C Rodriguez D Afchain A Capron C Dissous F Sntoro 1985 Major surface protein of Toxoplasma gondii (P30) contains an immunodominant region with repetitive epitopes Eur J Immunol 15 747 749 2408905 10.1002/eji.1830150721 1:CAS:528:DyaL2MXkvVKitb8%3D
24. M Rosado-Vallado M Mut-martiin M Garcia-Miss E Dumonteil 2005 Aluminum phosphate potentiates the efficacy of DNA vaccines against Leishmania mexicana Vaccine 23 5372 5379 16054271 10.1016/j.vaccine.2005.05.037 1:CAS:528: DC%2BD2MXht1Wisr7M
25. KS Rosenthal DH Zimmerman 2006 Vaccines: all things considered clinical and vaccine Immunology 13 821 829 1:CAS:528:DC%2BD28XosFCrsL0%3D
26. A Sadak Z Taghy B Fortier JF Dubremetz 1998 Characterization of a family of rhoptry proteins of Toxoplasma gondii Mol Biochem Parasitol 29 203 211 10.1016/0166-6851(88)90075-8
27. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Plainview
28. S Sasaki F Takeshita K-Q Xin N Ishii K Okuda 2003 Adjuvant formulations and delivery systems for DNA vaccines Methods 31 234 254 10.1016/S1046-2023(03) 00140-3
29. M Singh M Briones G Ott D O'Hagan 2000 Cationic microparticles: a potent delivery system for DNA vaccines Med Sci 97 811 816 1:CAS:528: DC%2BD3cXot1antQ%3D%3D
30. K Solhjoo F Ghaffari Far A Dalim-Asl Z Sharfi 2007 Enhancement of antibody immune response to a Toxoplasma gondii SAG1-encoded DNA vaccine by formulation with aluminum phosphate J Med Sci 7 361 367 10.3923/jms.2007.361.367 1:CAS:528:DC%2BD2sXnt1Slurs%3D
31. JB Ulmer CM Dewitt M Chastain A Friedman JJ Donnelly WL McClements MJ Caulfield KE Bohannon DB Volkin 2000 Enhancement of DNA vaccine potency using conventional aluminum adjuvants Vaccine 18 18 28 10.1016/S0264-410X(99)00151-6
32. M Vercommen T Scorza K Huygen JD Braekeleer R Diet D Jacobs E Saman H Verschueren 2000 DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, ROP2 induce partially protective immunity against lethal challenge in mice Infect Immun 68 38 45 10.1128/IAI.68.1.38-45.2000
33. Su Wang Xu Liu KG Fisher J Smith FW Chen TB Tobery JK Ulmer RJ Evans M Caulfield 2000 Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium-or aluminum phosphate Vaccine 18 1227 1235 10649624 10.1016/S0264-410X(99)00391-6 1:CAS:528:DC%2BD3cXnsFylug%3D%3D
34. MJ Wichroski JA Melton CG Donahue RK Tweten GE Ward 2002 Clostridium septicum alpha-toxin is active against the parasitic protozoa Toxoplasma gondii and targets membrane of the SAG family of glycosylphosphatidylinositol-anchored surface proteins Infect Immun 70 4353 4361 12117945 10.1128/IAI.70.8.4353-4361. 2002 1:CAS:528:DC%2BD38XlsFCmtL4%3D
35. M Xue S He Y Cui Y Yao H Wang 2008 Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii Parasitol Int 57 424 429 18562245 10.1016/j.parint.2008.05.001 1:CAS:528:DC%2BD1cXht1eisLzF
36. M Xue S He J Zhang Y Cui Y Yao H Wang 2008 Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine Exp Parasitol 119 352 357 18442818 10.1016/j.exppara.2008. 03.005 1:CAS:528:DC%2BD1cXmsFGksb4%3D
37. J Zhang S He H Jiang 2007 Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice Parasitol Res 101 331 338 17265053 10.1007/s00436-007-0465-3
38. CF Zinecker B Striepen H Geyer R Geyer J-F Dubremetz RT Schwarz 2001 Two glycoforms are present in the GPI-membrane anchor of the surface antigen 1 (P30) of Toxoplasma gondii Mol Biochem Parasitol 116 127 135 11522346 10.1016/S0166-6851(01)00313-9 1:CAS:528:DC%2BD3MXmtFWiur0%3D